Abstract：Objective To evaluate the effect of GTV volume on response of esophageal carcinoma.Methods From Jan.2004 to Dec.2008, 72 cases newly diagnosed N0 stage thoracic esophageal carcinomas were included in this retrospective study. All treatment plans were set up and designed by CT simulator and 3D TPS. They received dose 56-70 Gy/27-33F/6-7w with 6MV X-ray. The GTV, the tumor length and maximum diameters were measured on the treatment planning system with the X-ray. RECIST standard was applied to evaluate the radiotherapy response of esophageal carcinoma. The effectiveness of related prognostic factors on survival was evaluated by univariate analyses.Results The short-term response with CR were 79% with length <5 cm, 48% with 5-7 cm and 26% with length >7 cm(P=0.003).The 1-, 2-,3- and 5-year survival rates were 93%,79%,69%,69%;91%,61%,46%,46% and 80%,46%,28%,22%(P=0.037). The short-term response with CR were 56% with maximum diameters ≤3 cm and 33% with maximum diameters >3 cm(P=0.033).The 1- , 2- ,3- and 5-year survival rates were 91%,72%,55%,37% and 80%,45%,30%,30%(P=0.037). The short-term response with CR were 52% with GTV volume≤40 cm3 and 30% with GTV volume >40 cm3(P=0.059).The 1-, 2-,3- and 5-year survival rates were 91%,67%,51%,41% and 80%,43%,27%,27%(P=0.047).In the multivariate analysis, the length of GTV was likely to be the most important factor for the short-term response(P=0.005,0.014). Conclusions GTV volume, the tumor length and maximum diameters are factors for short-term response of N0 stage esophageal carcinoma. The GTV length is independent prognostic factor. The GTV length is the worse the prognosis will be.
Su Na,Wang Yadi,Li Chenglin et al. The effect of tumor length,maximum diameters and volume on the response of N0 stage thoracic esophageal squamous cell carcinoma [J]. Chinese Journal of Radiation Oncology, 2014, 23(1): 27-30.
[1]傅小龙.食管癌[A]//汤献猷.现代肿瘤学[M].上海:复旦大学出版社,2011:7-1. [2] 高献书,陈坤,周志国,等. 放射治疗食管癌CT分期的研究[J].河北医科大学学报,2003,24:153-154. [3] 肖泽芬.胸部肿瘤//殷蔚伯,谷铣之.肿瘤放射治疗学[M].3版.北京:中国协和医科大学出版社,2002:598-620. [4] 汪洋,施学辉,何少琴,等.超分割放射治疗食管癌的远期疗效和预后分析[J].中华放射肿瘤学杂志,2003,12:4-8. [5] 杨伟志.肿瘤的放射生物学概念[A]//殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].4 版.北京:中国协和医科大学出版社,2008:240-245. [6] 唐启信.临床放射生物学[M].北京:人民卫生出版社,2002:23-44. [7] 殷蔚伯.胸部肿瘤[A]//谷铣之,殷蔚伯,刘泰福,等.肿瘤放射治疗学[M].2版.北京:北京医科大学中国协和医科大学联合出版社,1993:493-509. [8] 马淑华,张志贤,殷蔚伯.人体体表肿瘤氧分压及低氧下的变化[J].中华放射肿瘤学杂志,1996,5:264-266. [9] Hckel M, Schlenger K, Mitze M, et al. Hypoxia and radiationresponse in human tumor[J]. Semin Radiat Oncol,1996,6:3-9. [10] Semenza GL. Intratumoral hypoxia, radiation resistance, and HIF-1[J]. Cancer Cell,2004,5:405-406. [11] Ciaccia AJ. Hypoxia stress proteins: survival of the fittest[J]. Semin Radiat Oncol,1996,6:46-58. [12] Bottaro DP, Liotta LA. Out of air is not out of action[J]. Nature,2003,423:593-595. [13] Sutherland RM, Ausserer WA, Murphy BJ, et al. Tumor hypoxia and heterogenity: challenges and opportunities for the future[J]. Semin Radiat Oncol,1996,6:59-70. [14] 陆雪官,冯炎,胡超苏.恶性肿瘤乏氧细胞研究现状[J].中华放射肿瘤学杂志,1999,8:57-58. [15] Chang CC, Chen MK, Liu MT, et al. The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors[J]. Head Neck,2002,24:940-946. [16] 方德康,汪良骏,张大为,等.贲门癌最大径分级与预后的关系探讨[J].中华肿瘤杂志,2000,22:161-163. [17] Richtig E, Langmann G, Müllner K, et al.Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas[J]. Eye (Lond),2004,18:619-623. [18] Dubben HH, Thames HD, Beck-Bornholdt HP. Tumor volume: a basic and specific response predictor in radiotherapy[J]. Radiother Oncol,1998,47:167-174. [19] 周明镇,陈志坚,洪红光,等.食管癌大体肿瘤体积对放射治疗近期疗效影响[J].中国肿瘤,2004,13:181-183. [20] 陈明秋,林庆良,张莹莹,等.影响食管癌放射治疗近期疗效的大体肿瘤因素分析[J].癌症进展杂志,2009,11:648-653. [21] Eloubeidi MA, Desmond R, Arguedss MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the US[J].Cancer,2002,95:1434-1443. [22] 刘明,李彩英,章俊杰,等.食管癌病变长度与浸润深度关系的探讨[J].中国医学影像技术,2003,19:885-886. [23] 卢晓红.食管癌放射治疗后近期死亡原因分析[J].肿瘤防治杂志,2000,7:320-321. [24] 卢铀,李涛,王捷,等.食管癌长度与癌外侵及淋巴结转移的关系[J].中国肿瘤临床,1997,24:146. [25] 李涛,卢铀,王捷,等.194 例超长食管癌不同治疗方法疗效分析[J].中华放射肿瘤学杂志,1997,6.221-222. [26] Weinberg JA. The intrathoracic lymphatics//Haagensen CD. The lymphatics in cancer[M]. Philadelphia: WB Saunders,1972:245-249. [27] 王旭广,毛志福,师晓天,等.胸段食管鳞癌淋巴结合理廓清范围的探讨[J].中国胸心血管外科临床杂志,2005,12:136-138. [28] 祝淑钗,李仁,王玉祥,等.500例中晚期食管癌单纯放疗的多因素分析[J].中华放射肿瘤学杂志,2005,14:253-258. [29] 张合林,平育敏,杜喜群,等.应用Cox模型分析影响食管癌切除术后的预后因素[J].中华肿瘤杂志,1999,21:32-34. [30] 谢映涛,王树钦,黄金球,等.影响胸段食管癌切除术预后的因素[J].中华胃肠外科杂志,2004,7:453-455. [31] Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET[J]. Chest Surg Clin N Am,2000,10:471-485. [32] Tachibana M, Dhar DK, Kinugasa S, et al. Esophageal cancerw ith distant lymph node metastasis: prognostic significance of metastatic lymph node ratio[J]. J Clin Gastroenterol,2000,31:318-322. [33] 施学辉,吴广丰,姚伟强,等.食管癌放射治疗照射野大小的预测[J].中华放射肿瘤学杂志,1992,1:219-222.
2014, Vol. 23 
